An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

NCT05217628 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Trigeminal Neuralgia

Interventions

DRUG: Basimglurant
OTHER: Placebo

Sponsor

Noema Pharma AG